tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Income Statement

Compare
1,342 Followers

Vir Biotechnology Income Statement

Last quarter (Q4 2024), Vir Biotechnology's total revenue was $11.28M, a decrease of -32.82% from the same quarter last year. In Q4, Vir Biotechnology's net income was $-104.59M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 74.20M$ 86.18M$ 1.58B$ 1.09B$ 67.25M
Gross Profit
$ 73.36M$ 83.42M$ 1.43B$ 1.02B$ -234.33M
Operating Expenses
$ 660.52M$ 767.72M$ 601.09M$ 600.45M$ 364.23M
Depreciation and Amortization
$ 14.56M$ 19.45M$ 15.49M$ 11.98M$ 8.81M
EBITDA
$ -537.61M$ -664.85M$ 833.07M$ 420.75M$ -289.80M
Operating Income
$ -587.16M$ -684.30M$ 833.07M$ 276.89M$ -296.98M
Other Income/Expenses
$ 64.06M$ 56.11M$ -78.79M$ 129.05M$ -1.63M
Pretax Income
$ -523.11M$ -628.19M$ 754.28M$ 549.80M$ -298.61M
Net Income
$ -521.96M$ -615.06M$ 515.84M$ 528.58M$ -298.67M
Per Share Metrics
Basic EPS
$ -3.83$ -4.59$ 3.89$ 4.07$ -2.51
Diluted EPS
$ -3.83$ -4.59$ 3.83$ 3.96$ -2.51
Weighted Average Shares Outstanding
136.25M 134.13M 132.61M 129.88M 119.16M
Weighted Average Shares Outstanding (Diluted)
136.25M 134.13M 134.81M 133.44M 119.16M
Currency in USD

Vir Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis